Business Review
POLYDOC PLC
25 August 1999
PolyDoc Plc
SHAREHOLDER COMMUNICATION
A business review of the first half of 1999
and the outlook for the remainder of the year
from
Barry Mence, Executive Chairman
PolyDoc, a computer software company, which specialises in the
development and provision of business solutions in the rapidly
growing field of Knowledge Management announces its business
highlights for the first half of 1999.
Highlights:
- Consistent levels of revenue from our long term contracts
to install QualiFlow, our healthcare industry product,
continue to form the foundation of our turnover. This revenue
has been supplemented by both product and consultancy sales.
Total turnover has shown a 14% increase compared to the same
period in the previous year. With operating costs increasing
in line with budget, pre-tax losses will be around £600,000
- Lessenger B.V., PolyDocs recently acquired supplier of
document management software to the healthcare industry,
brings additional revenue from both new and its existing 50
Dutch healthcare clients
- StudyFlow pilot successfully evaluated by DERA, the
Defence Evaluation and Research Agency related to the UK
Ministry of Defence, resulting in additional development work
being contracted
- Knowledge Management Consultancy division launched and
starting to contract first customers
- PolyDoc and Hiscom announce agreement to collaborate on
Medical Knowledge Management Systems to accelerate progress
towards electronic patient dossiers for Dutch healthcare
market
- Letter of intent signed to acquire AppliedNet, a UK-based
knowledge management software products, systems integration
and consulting company. This would add a complementary product
set, a solid blue-chip UK customer base, an additional
existing revenue stream and more than 40 highly skilled UK
staff.
- First important business partnership agreements entered
into in the UK and the USA
- Senior software industry executive, Paul Heller, is
appointed as Chief Technology Officer and a member of the
management board of directors
CHAIRMANS LETTER TO SHAREHOLDERS
With the first half of 1999 now completed I would like to
update you on PolyDocs progress during the past half year and
to share with you our major objectives for the rest of the
current year and beyond.
Business review of the first half of 1999.
Healthcare.
Our first multimillion guilder contract involving three (from
a total of eight) academic/teaching hospitals in the
Netherlands is progressing well. Our QualiFlow software has
continued to be delivered to the initial customers in the
stages as planned enabling them to prepare for the important
phase of content production. With further deliveries planned
for October 1999 the environment has been created for all
sizes of hospital to become customers of both QualiFlow
software and content. We have had clear indications from the
highest level at several hospitals, both academic and general,
that they intend to contract for PolyDocs software to enable
them to share the content with the first launching customers.
We expect to sign further substantial business in this area
during the current year, as we seek to establish our approach
as a form of standard for the Dutch healthcare industry.
As mentioned in a previous shareholder communication, a joint
venture company called Pro-GRAM B.V. has been formed by the
initial academic hospitals to market, together with PolyDoc,
the QualiFlow software and the knowledge created using the
software to a broad range of organisations in the Dutch
healthcare industry. PolyDoc has accepted an invitation to
become a shareholder in this company, which has at the start
of this year commenced active marketing.
Lessenger B.V., our recently acquired supplier of document
management software to the healthcare industry, has been fully
integrated into PolyDocs business. This has started to bring
additional revenue from both new and its existing 50 Dutch
healthcare clients. In addition to our commitment to the
ongoing development, enhancement and support of these
products, we will also ensure that our QualiFlow healthcare
solution interfaces with the Lessenger family of products.
This should put both PolyDoc and Pro-GRAM in a strong position
to further accelerate our sales of QualiFlow in the
substantial healthcare market.
We have entered agreements with Hiscom in the Netherlands and
Marlow in the U.K. which are more fully described under the
Business Partnership section of this note. We are also in
discussions in the U.K., U.S.A., Belgium and Germany with
prospects and additional business partners that have shown
serious interest in our Healthcare solution QualiFlow.
Manufacturing and Defence.
DSM, the multinational chemical manufacturer, went into full
production early this year with the latest version (3.0) of
NormFlow, our solution for the production and maintenance of
standards for the manufacturing and process industries. We
have extended the scope and use of the product at DSM
resulting in additional revenue on top of the ongoing
maintenance fees.
We have contracted the services of two former senior
executives of the Baan Company, Otto van der Tang and Henk
Speksnijder to initiate the volume selling of this new
enhanced NormFlow as well as the marketing of our
ResearchFlow/StudyFlow solutions into this sector. This is
presently underway, and we would expect to see the commercial
results of this starting during the current year.
The StudyFlow pilot we have been executing at DERA, the
Defence Evaluation and Research Agency related to the UK
Ministry of Defence, has been successfully evaluated resulting
in further development work being contracted.
Our plans for penetrating the Defence Industry have become
closely linked to our Manufacturing strategy. This is because
our early prospects apart from DERA are major defence industry
manufacturers. One of these manufacturers is at the final
stages of evaluating the implementation and benefits of
PolyDocs solutions, and we would expect to see further work
with that organisation and DERA in the second half of this
year.
Knowledge and Content Management Consultancy Services.
Our new consultancy services group has now been established
and is focussing on generating additional revenue as well as
bringing potential software product customers and business
partners into PolyDoc as paying services customers. Initial
work of this nature has been contracted with DSM, Oci, DERA,
IBM and KPMG in the first half of this year.
Business Partnerships.
Our strategy for expanding PolyDocs business into volume
sales has always been to enter into business partnerships with
mature organisations with strong customer bases, once we have
established the early customers in our chosen focus
industries. The initial target geographies remain the Benelux
countries, the UK and the USA.
In addition to the partnership covering the Benelux with the
hospitals joint venture company, Pro-GRAM we have put two non-
exclusive agreements in place with business partners in the
United Kingdom and the United States. Marlow Consulting in
United Kingdom specialises in management consultancy and
systems integration, and they are focusing with PolyDocs
products on a number of named accounts in the healthcare and
pharmaceutical industries. TelTech, a recognised USA Knowledge
Management specialist-consulting firm will be focussing on the
manufacturing industry. All three partners have been working
closely with PolyDoc staff on concrete business opportunities
in the Netherlands, USA, UK and Germany. We are also in
detailed discussions with a small number of software suppliers
with substantial existing customer bases concerning the
integration of parts of our software into theirs, which we
believe could potentially form the start of a very lucrative
revenue stream. Another important agreement we have entered
into is with Hiscom in the Netherlands whereby we are to
collaborate on medical knowledge systems to accelerate
progress towards electronic patient dossiers for the Dutch
healthcare market. Hiscom is the market leader in the medical
IT market in the Netherlands, and is increasingly focusing on
new Care information systems outside its local market, in
particular in the United Kingdom, Germany and Scandinavia. We
are currently discussing the potential for jointly pursuing
commercial opportunities also in these geographies.
Financial.
Consistent levels of revenue from our long term contracts to
install QualiFlow, our major healthcare industry product,
continue to form the foundation of our turnover. This revenue
has been supplemented by both Lessenger product and
consultancy sales from our recently formed Consultancy group.
Total turnover has shown a 14% increase compared to the same
period in the previous year. With operating costs increasing
in line with budget, pre-tax losses will be around £600,000.
The convertible loan that was put in place last year was an
interim term solution for our medium term capital
requirements. These funds have been utilised to a point where
as announced previously, we need to complete further more
substantial fund raising in this current year. Initial
indications from Institutions in the U.K. Financial Market
have been positive as born out by the issuing of £500,000 of
new ordinary shares to three new institutional investors
earlier this year, at market price at the time (£1.47).
The new funds to be raised will ensure we have the cash in
place to meet our ongoing financial requirements, and to build
upon our business successes in the Healthcare industry, by
expanding into the UK and USA markets, replicating the
successful formula we have developed in the Netherlands.
Additionally, we will then be in a position to more fully
exploit our potential in the lucrative Manufacturing and
Defence industries, where we are currently working with our
initial customers as mentioned earlier in this document.
Further details of this fund raising will be announced during
the coming months.
Outlook for the second half of 1999 and beyond
Following the successful integration of our first acquisition
and in line with our acquisition strategy, we are actively
working with a number of European companies to evaluate the
benefits of them becoming part of PolyDoc. The most important
development in this area is the signing of a letter of intent
to purchase AppliedNet, a UK-based software products, systems
integration and consulting company. Upon completion this will
be a significant step forward and a major milestone in our
business development, with the acquisition providing the
necessary critical mass and additional resources to broaden
and accelerate sales in the European marketplace, and to
expand faster into the United States. Additionally,
AppliedNets impressive UK client portfolio, comprising blue-
chip multinationals, defence and publishing organisations,
would significantly enhance our overall customer base and
brings an important further revenue stream. We firmly believe
that the combination of AppliedNets knowledge harvesting
software and web publishing solutions together with PolyDocs
knowledge capture and content management software would create
a very competitive and highly commercial range of solutions in
the fast emerging knowledge management and e-business
marketplaces. With our push into the United States starting to
take shape via our business partnership agreements and our
small team of senior executives led by Paul Heller, we are
then targeting the year 2000 for an acquisition in that
territory.
Recent months have seen several important announcements in the
Knowledge Management arena from market leader software
companies like Microsoft. Not only is this starting to
increase potential customers focus on purchasing Knowledge
Management software, it is adding substantial credibility to
PolyDocs software solutions. In particular, this is because
our software is complementary to that being brought to market
by the likes of Microsoft and also that we actually integrate
the technology from several leading suppliers, such as
Microsoft and Oracle, into our Knowledge Management
applications.
1999 has so far been a year of considerable progress for
PolyDoc that to-date has not substantially impacted our
revenue figures. The benefits of this should have a more
substantial impact in the second half of this year with
revenue generation being anticipated in most, if not all, of
the above mentioned areas. These developments together with
the completion of our next round of fund raising will form the
foundation from which to move the business forward at an
enhanced pace, which in-turn should bring exciting times for
both PolyDocs shareholders and staff in the new millennium.
Barry Mence or Richard Maddocks (PolyDoc) 0031 20 301 3900
rma@polydoc.com
Steve Liebmann (Buchanan Communications) 0171 466 5000
stevel@buchanan.uk.com